메뉴 건너뛰기




Volumn 33, Issue 2, 2005, Pages 77-83

The role of plasma N-terminal pro B-type natriuretic peptide to predict the clinical course of patients with hypertrophic cardiomyopathy;Hipertrofik kardiyomiyopatide klinik seyrin öngörülmesinde plazma N-terminal pro B-tip natriüretik peptid düzeyinin rolü

Author keywords

Biological markers blood; Cardiomyopathy, hypertrophic blood; Echocardiography, doppler; Natriuretic peptide, brain blood; Ventricular dysfunction

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; N TERMINAL PRO BRAIN NATRIURETRIC PEPTIDE; PROTEIN PRECURSOR; UNCLASSIFIED DRUG;

EID: 26644468133     PISSN: 10165169     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (1)

References (25)
  • 1
    • 0037070514 scopus 로고    scopus 로고
    • Hypertrophic cardiomyopathy: A systematic review
    • Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002;287:1308-20.
    • (2002) JAMA , vol.287 , pp. 1308-1320
    • Maron, B.J.1
  • 2
    • 0028849972 scopus 로고
    • Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: Morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients
    • Klues HG, Schiffers A, Maron BJ. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol 1995;26:1699-708.
    • (1995) J Am Coll Cardiol , vol.26 , pp. 1699-1708
    • Klues, H.G.1    Schiffers, A.2    Maron, B.J.3
  • 3
    • 0032103098 scopus 로고    scopus 로고
    • Implications of left ventricular remodeling in hypertrophic cardiomyopathy
    • Maron BJ, Spirito P. Implications of left ventricular remodeling in hypertrophic cardiomyopathy. Am J Cardiol 1998;81:1339-44.
    • (1998) Am J Cardiol , vol.81 , pp. 1339-1344
    • Maron, B.J.1    Spirito, P.2
  • 5
    • 0026532927 scopus 로고
    • Diversity of structural mitral valve alterations in hypertrophic cardiomyopathy
    • Klues HG, Maron BJ, Dollar AL, Roberts WC. Diversity of structural mitral valve alterations in hypertrophic cardiomyopathy. Circulation 1992;85: 1651-60.
    • (1992) Circulation , vol.85 , pp. 1651-1660
    • Klues, H.G.1    Maron, B.J.2    Dollar, A.L.3    Roberts, W.C.4
  • 6
    • 0018675177 scopus 로고
    • Hypertrophic nonobstructive cardiomyopathy with giant negative T waves (apical hypertrophy): Ventriculographic and echocardiographic features in 30 patients
    • Yamaguchi H, Ishimura T, Nishiyama S, Nagasaki F, Nakanishi S, Takatsu F, et al. Hypertrophic nonobstructive cardiomyopathy with giant negative T waves (apical hypertrophy): ventriculographic and echocardiographic features in 30 patients. Am J Cardiol 1979; 44:401-12.
    • (1979) Am J Cardiol , vol.44 , pp. 401-412
    • Yamaguchi, H.1    Ishimura, T.2    Nishiyama, S.3    Nagasaki, F.4    Nakanishi, S.5    Takatsu, F.6
  • 7
    • 0023128040 scopus 로고
    • Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (2)
    • Maron BJ, Bonow RO, Cannon RO 3rd, Leon MB, Epstein SE. Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (2). N Engl J Med 1987;316:844-52.
    • (1987) N Engl J Med , vol.316 , pp. 844-852
    • Maron, B.J.1    Bonow, R.O.2    Cannon III, R.O.3    Leon, M.B.4    Epstein, S.E.5
  • 8
    • 0027247910 scopus 로고
    • Coexistence of sudden cardiac death and end-stage heart failure in familial hypertrophic cardiomyopathy
    • Hecht GM, Klues HG, Roberts WC, Maron BJ. Coexistence of sudden cardiac death and end-stage heart failure in familial hypertrophic cardiomyopathy. J Am Coll Cardiol 1993;22:489-97.
    • (1993) J Am Coll Cardiol , vol.22 , pp. 489-497
    • Hecht, G.M.1    Klues, H.G.2    Roberts, W.C.3    Maron, B.J.4
  • 9
    • 0032785114 scopus 로고    scopus 로고
    • Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1
    • Tsutamoto T, Wada A, Maeda K, Hisanaga T, Mabuchi N, Hayashi M, et al. Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1. Eur Heart J 1999;20:1799-807.
    • (1999) Eur Heart J , vol.20 , pp. 1799-1807
    • Tsutamoto, T.1    Wada, A.2    Maeda, K.3    Hisanaga, T.4    Mabuchi, N.5    Hayashi, M.6
  • 10
    • 0034176934 scopus 로고    scopus 로고
    • Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations
    • Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls MG, Richards AM. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 2000; 355:1126-30.
    • (2000) Lancet , vol.355 , pp. 1126-1130
    • Troughton, R.W.1    Frampton, C.M.2    Yandle, T.G.3    Espiner, E.A.4    Nicholls, M.G.5    Richards, A.M.6
  • 11
    • 0032546646 scopus 로고    scopus 로고
    • Plasma N-terminal probrain natriuretic peptide and adrenomedullin: New neurohormonal predictors of left ventricular function and prognosis after myocardial infarction
    • Richards AM, Nicholls MG, Yandle TG, Frampton C, Espiner EA, Turner JG, et al. Plasma N-terminal probrain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 1998; 97:1921-9.
    • (1998) Circulation , vol.97 , pp. 1921-1929
    • Richards, A.M.1    Nicholls, M.G.2    Yandle, T.G.3    Frampton, C.4    Espiner, E.A.5    Turner, J.G.6
  • 12
    • 0029948712 scopus 로고    scopus 로고
    • Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide
    • Omland T, Aakvaag A, Bonarjee VV, Caidahl K, Lie RT, Nilsen DW, et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation 1996;93:1963-9.
    • (1996) Circulation , vol.93 , pp. 1963-1969
    • Omland, T.1    Aakvaag, A.2    Bonarjee, V.V.3    Caidahl, K.4    Lie, R.T.5    Nilsen, D.W.6
  • 14
    • 3843098192 scopus 로고    scopus 로고
    • N-terminal pro-brain natriuretic peptide predicts cardiovascular events in patients with hypertension and left ventricular hypertrophy: A LIFE study
    • Olsen MH, Wachtell K, Tuxen C, Possum E, Bang LE, Hall C, et al. N-terminal pro-brain natriuretic peptide predicts cardiovascular events in patients with hypertension and left ventricular hypertrophy: a LIFE study. J Hypertens 2004;22:1597-604.
    • (2004) J Hypertens , vol.22 , pp. 1597-1604
    • Olsen, M.H.1    Wachtell, K.2    Tuxen, C.3    Possum, E.4    Bang, L.E.5    Hall, C.6
  • 15
    • 0037461605 scopus 로고    scopus 로고
    • Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy
    • Maron MS, Olivotto I, Betocchi S, Casey SA, Lesser JR, Losi MA, et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 2003;348:295-303.
    • (2003) N Engl J Med , vol.348 , pp. 295-303
    • Maron, M.S.1    Olivotto, I.2    Betocchi, S.3    Casey, S.A.4    Lesser, J.R.5    Losi, M.A.6
  • 16
    • 0027255523 scopus 로고
    • Ventricular expression of brain natriuretic peptide in hypertrophic cardiomyopathy
    • Hasegawa K, Fujiwara H, Doyama K, Miyamae M, Fujiwara T, Suga S, et al. Ventricular expression of brain natriuretic peptide in hypertrophic cardiomyopathy. Circulation 1993;88:372-80.
    • (1993) Circulation , vol.88 , pp. 372-380
    • Hasegawa, K.1    Fujiwara, H.2    Doyama, K.3    Miyamae, M.4    Fujiwara, T.5    Suga, S.6
  • 17
    • 0034898403 scopus 로고    scopus 로고
    • Determinants and clinical significance of natriuretic peptides and hypertrophic cardiomyopathy
    • Briguori C, Betocchi S, Manganelli F, Gigante B, Losi MA, Ciampi Q, et al. Determinants and clinical significance of natriuretic peptides and hypertrophic cardiomyopathy. Eur Heart J 2001;22:1328-36.
    • (2001) Eur Heart J , vol.22 , pp. 1328-1336
    • Briguori, C.1    Betocchi, S.2    Manganelli, F.3    Gigante, B.4    Losi, M.A.5    Ciampi, Q.6
  • 18
    • 1342291266 scopus 로고    scopus 로고
    • Application of NT-proBNP and BNP measurements in cardiac care: A more discerning marker for the detection and evaluation of heart failure
    • Seino Y, Ogawa A, Yamashita T, Fukushima M, Ogata K, Fukumoto H, et al. Application of NT-proBNP and BNP measurements in cardiac care: a more discerning marker for the detection and evaluation of heart failure. Eur J Heart Fail 2004;6:295-300.
    • (2004) Eur J Heart Fail , vol.6 , pp. 295-300
    • Seino, Y.1    Ogawa, A.2    Yamashita, T.3    Fukushima, M.4    Ogata, K.5    Fukumoto, H.6
  • 19
    • 0037094266 scopus 로고    scopus 로고
    • Increased plasma brain natriuretic peptide level as a guide for silent myocardial ischemia in patients with non-obstructive hypertrophic cardiomyopathy
    • Nakamura T, Sakamoto K, Yamano T, Kikkawa M, Zen K, Hikosaka T, et al. Increased plasma brain natriuretic peptide level as a guide for silent myocardial ischemia in patients with non-obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 2002;39:1657-63.
    • (2002) J Am Coll Cardiol , vol.39 , pp. 1657-1663
    • Nakamura, T.1    Sakamoto, K.2    Yamano, T.3    Kikkawa, M.4    Zen, K.5    Hikosaka, T.6
  • 21
    • 1442311387 scopus 로고    scopus 로고
    • Usefulness of B-type natriuretic peptide assay in the assessment of symptomatic state in hypertrophic cardiomyopathy
    • Maron BJ, Tholakanahalli VN, Zenovich AG, Casey SA, Duprez D, Aeppli DM, et al. Usefulness of B-type natriuretic peptide assay in the assessment of symptomatic state in hypertrophic cardiomyopathy. Circulation 2004; 109:984-9.
    • (2004) Circulation , vol.109 , pp. 984-989
    • Maron, B.J.1    Tholakanahalli, V.N.2    Zenovich, A.G.3    Casey, S.A.4    Duprez, D.5    Aeppli, D.M.6
  • 22
    • 5644268954 scopus 로고    scopus 로고
    • N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients
    • Bettencourt P, Azevedo A, Pimenta J, Frioes F, Ferreira S, Ferreira A. N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 2004;110:2168-74.
    • (2004) Circulation , vol.110 , pp. 2168-2174
    • Bettencourt, P.1    Azevedo, A.2    Pimenta, J.3    Frioes, F.4    Ferreira, S.5    Ferreira, A.6
  • 24
    • 0030806988 scopus 로고    scopus 로고
    • Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction
    • Tsutamoto T, Wada A, Maeda K, Hisanaga T, Maeda Y, Fukai D, et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 1997; 96:509-16.
    • (1997) Circulation , vol.96 , pp. 509-516
    • Tsutamoto, T.1    Wada, A.2    Maeda, K.3    Hisanaga, T.4    Maeda, Y.5    Fukai, D.6
  • 25
    • 0037157566 scopus 로고    scopus 로고
    • Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: Cohort study in representative and high risk community populations
    • Hobbs FD, Davis RC, Roalfe AK, Hare R, Davies MK, Kenkre JE. Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations. BMJ 2002;324:1498.
    • (2002) BMJ , vol.324 , pp. 1498
    • Hobbs, F.D.1    Davis, R.C.2    Roalfe, A.K.3    Hare, R.4    Davies, M.K.5    Kenkre, J.E.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.